Kestra Medical Technologies, Ltd. (KMTS)
$26.98+4.70%Close
BUYBEAR · day 2
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1.6B
- Beta
- 0.62
- P/E (TTM)
- -10.15
- Short % float
- 10.04%
- Days to cover
- 7.3
- SI change
- +4.9%
- 1W
- -1.64%
- 1M
- +14.47%
- vs SPY 1W
- -2.80%
- vs SPY 1M
- +11.48%
Industry peers
FMP comparable companies · ranked by market cap
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 5
- VALUE
- 0
- GROWTH
- 18
- GARP
- 11
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-38.5%
REV YoY-
ROE-15.0%
EPS YoY-
ROA-43.1%
GROSS54
OP-134
NET-140
[VALUATION]
P/E TTM-10.15
P/E FWD-
SECTOR PE20.47
INDUSTRY PE45.68
P/B7.14
P/FCF-
EV/EBITDA-11.09
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E34.38
ALTMAN Z-
CURR RATIO4.69
ND/EBITDA-
BETA0.62
NET INCOME (TTM) < 0
Company news
FAQ
- What is LOPJLB’s current signal on KMTS?
- LOPJLB’s latest quantitative signal on Kestra Medical Technologies, Ltd. (KMTS) is BUY in a BEAR regime. Signals are updated daily.
- What market regime is KMTS in?
- Kestra Medical Technologies, Ltd. (KMTS) is currently classified in the BEAR HMM market regime on LOPJLB.
- What does Kestra Medical Technologies, Ltd. (KMTS) do?
- Kestra Medical Technologies, Ltd. operates at the intersection of wearable medical technology and digital healthcare. Its core mission is to revolutionize patient outcomes in cardiovascular disease through intelligent, intuitive, and connected monitoring and therapeutic intervention solutions. The company's flagship offering is the Cardiac Recovery System (CRS) platform, which it develops and c…